The reduction in visceral fat mass in response to growth hormone is more marked in men than in oestrogen-deficient women

Growth Hormone and IGF Research

Volumn 19, Issue 2, 2009, Pages 112-120

  Franco, Celina ^a   Koranyi, Josef ^a   Brandberg, John ^a   Lönn, Lars ^a   Bengtsson, Bengt Åke ^a   Svensson, Johan ^a   Johannsson, Gudmundur ^a  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Abdominal obesity; Adipokines; Androgens; Gender difference; Growth hormone; Insulin sensitivity; Metabolic syndrome; Oestrogen; Regional adipose tissue distribution

Indexed keywords

ESTROGEN; GROWTH HORMONE; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; POTASSIUM 40;

ABDOMINAL OBESITY; ADIPOSE TISSUE; ADULT; ARTHRALGIA; ARTICLE; BEDTIME DOSAGE; BODY COMPOSITION; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DRUG ACTIVITY; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG RESPONSE; ESTROGEN DEFICIENCY; FEMALE; FLUID RETENTION; GLUCOSE CLAMP TECHNIQUE; GROWTH HORMONE DEFICIENCY; HUMAN; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; JOINT STIFFNESS; LOW DRUG DOSE; MALE; MUSCLE MASS; PATIENT COMPLIANCE; PERIPHERAL EDEMA; POSTMENOPAUSE; PRIORITY JOURNAL; SEX DIFFERENCE; SIDE EFFECT; WAIST CIRCUMFERENCE;

BODY COMPOSITION; FEMALE; GLUCOSE TOLERANCE TEST; HORMONE REPLACEMENT THERAPY; HUMAN GROWTH HORMONE; HUMANS; INSULIN; INSULIN-LIKE GROWTH FACTOR I; INTRA-ABDOMINAL FAT; LIPIDS; MALE; MIDDLE AGED; POSTMENOPAUSE; POTASSIUM; SEX FACTORS;

EID: 61649100301     PISSN: 10966374     EISSN: 15322238     Source Type: Journal    
DOI: 10.1016/j.ghir.2008.07.001     Document Type: Article

References (35)

1. Ho K.K., Gibney J., Johannsson G., and Wolthers T. Regulating of growth hormone sensitivity by sex steroids: implications for therapy. Front. Horm. Res. 35 (2006) 115-128
2. Chumlea W.C., Guo S.S., Zeller C.M., Reo N.V., Baumgartner R.N., Garry P.J., Wang J., Pierson Jr. R.N., Heymsfield S.B., and Siervogel R.M. Total body water reference values and prediction equations for adults. Kidney Int. 59 (2001) 2250-2258
3. Chumlea W.C., Guo S.S., Zeller C.M., Reo N.V., and Siervogel R.M. Total body water data for white adults 18 to 64 years of age: the Fels Longitudinal Study. Kidney Int. 56 (1999) 244-252
4. Nindl B.C., Scoville C.R., Sheehan K.M., Leone C.D., and Mello R.P. Gender differences in regional body composition and somatotrophic influences of IGF-I and leptin. J. Appl. Physiol. 92 (2002) 1611-1618
5. Kvist H., Chowdhury B., Grangard U., Tylen U., and Sjostrom L. Total and visceral adipose-tissue volumes derived from measurements with computed tomography in adult men and women: predictive equations. Am. J. Clin. Nutr. 48 (1988) 1351-1361
6. Lemieux S., Prud'homme D., Bouchard C., Tremblay A., and Despres J.P. Sex differences in the relation of visceral adipose tissue accumulation to total body fatness. Am. J. Clin. Nutr. 58 (1993) 463-467
7. Enzi G., Gasparo M., Biondetti P.R., Fiore D., Semisa M., and Zurlo F. Subcutaneous and visceral fat distribution according to sex, age, and overweight, evaluated by computed tomography. Am. J. Clin. Nutr. 44 (1986) 739-746
8. Silha J.V., Krsek M., Skrha J.V., Sucharda P., Nyomba B.L., and Murphy L.J. Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 149 (2003) 331-335
9. Montague C.T., Prins J.B., Sanders L., Digby J.E., and O'Rahilly S. Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46 (1997) 342-347
10. Wajchenberg B.L. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr. Rev. 21 (2000) 697-738
11. Nishizawa H., Shimomura I., Kishida K., Maeda N., Kuriyama H., Nagaretani H., Matsuda M., Kondo H., Furuyama N., Kihara S., Nakamura T., Tochino Y., Funahashi T., and Matsuzawa Y. Androgens decrease plasma adiponectin, an insulin-sensitizing adipocyte-derived protein. Diabetes 51 (2002) 2734-2741
12. Johannsson G., Bjarnason R., Bramnert M., Carlsson L.M., Degerblad M., Manhem P., Rosen T., Thoren M., and Bengtsson B.A. The individual responsiveness to growth hormone (GH) treatment in GH-deficient adults is dependent on the level of GH-binding protein, body mass index, age, and gender. J. Clin. Endocrinol. Metab. 81 (1996) 1575-1581
13. Burman P., Johansson A.G., Siegbahn A., Vessby B., and Karlsson F.A. Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J. Clin. Endocrinol. Metab. 82 (1997) 550-555
14. Johansson A.G., Engstrom B.E., Ljunghall S., Karlsson F.A., and Burman P. Gender differences in the effects of long term growth hormone (GH) treatment on bone in adults with GH deficiency. J. Clin. Endocrinol. Metab. 84 (1999) 2002-2007
15. Franco C., Brandberg J., Lonn L., Andersson B., Bengtsson B.A., and Johannsson G. Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial. J. Clin. Endocrinol. Metab. 90 (2005) 1466-1474
16. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am. J. Physiol. 237 (1979) E214-E223
17. Bokemark L., Froden A., Attvall S., Wikstrand J., and Fagerberg B. The euglycemic hyperinsulinemic clamp examination: variability and reproducibility. Scand. J. Clin. Lab. Invest. 60 (2000) 27-36
18. Landin-Wilhelmsen K., Wilhelmsen L., Lappas G., Rosen T., Lindstedt G., Lundberg P.A., and Bengtsson B.A. Serum insulin-like growth factor I in a random population sample of men and women: relation to age, sex, smoking habits, coffee consumption and physical activity, blood pressure and concentrations of plasma lipids, fibrinogen, parathyroid hormone and osteocalcin. Clin. Endocrinol. (Oxf) 41 (1994) 351-357
19. Chowdhury B., Sjostrom L., Alpsten M., Kostanty J., Kvist H., and Lofgren R. A multicompartment body composition technique based on computerized tomography. Int. J. Obes. Relat. Metab. Disord. 18 (1994) 219-234
20. Starck G., Lonn L., Cederblad A., Forssell-Aronsson E., Sjostrom L., and Alpsten M. A method to obtain the same levels of CT image noise for patients of various sizes, to minimize radiation dose. Brit. J. Radiol. 75 (2002) 140-150
21. Goodpaster B.H., Kelley D.E., Thaete F.L., He J., and Ross R. Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content. J. Appl. Physiol. 89 (2000) 104-110
22. Boseaus I., Johannsson G., Rosen T., Hallgren P., Tölli J., Sjöström L., and Bengtsson B.A. Comparison of methods to estimate body fat in growth hormone deficient adults. Clin. Endocrinol. 44 (1996) 395-402
23. Brown H., and Prescott R. Applied Mixed Models in Medicine. second ed. (2006), Wiley, Chichester
24. Pasarica M., Zachwieja J.J., Dejonge L., Redman S., and Smith S.R. Effect of growth hormone on body composition and visceral adiposity in middle-aged men with visceral obesity. J. Clin. Endocrinol. Metab. 92 (2007) 4265-4270
25. Brummer R.J., Lonn L., Kvist H., Grangard U., Bengtsson B.A., and Sjostrom L. Adipose tissue and muscle volume determination by computed tomography in acromegaly, before and 1 year after adenomectomy. Eur. J. Clin. Invest. 23 (1993) 199-205
26. Leung K.C., Johannsson G., Leong G.M., and Ho K.K. Estrogen regulation of growth hormone action. Endocr. Rev. 25 (2004) 693-721
27. Yang S., Xu X., Bjorntorp P., and Eden S. Additive effects of growth hormone and testosterone on lipolysis in adipocytes of hypophysectomized rats. J. Endocrinol. 147 (1995) 147-152
28. Lukanova A., Lundin E., Zeleniuch-Jacquotte A., Muti P., Mure A., Rinaldi S., Dossus L., Micheli A., Arslan A., Lenner P., Shore R.E., Krogh V., Koenig K.L., Riboli E., Berrino F., Hallmans G., Stattin P., Toniolo P., and Kaaks R. Body mass index, circulating levels of sex-steroid hormones, IGF-I and IGF-binding protein-3: a cross-sectional study in healthy women. Eur. J. Endocrinol. 150 (2004) 161-171
29. Siiteri P.K. Post-menopausal estrogen production. Front. Horm. Res. 3 (1975) 40-44
30. Grodin J.M., Siiteri P.K., and MacDonald P.C. Source of estrogen production in postmenopausal women. J. Clin. Endocrinol. Metab. 36 (1973) 207-214
31. Brabant G., von zur Muhlen A., Wuster C., Ranke M.B., Kratzsch J., Kiess W., Ketelslegers J.M., Wilhelmsen L., Hulthen L., Saller B., Mattsson A., Wilde J., Schemer R., and Kann P. Serum insulin-like growth factor I reference values for an automated chemiluminescence immunoassay system: results from a multicenter study. Horm. Res. 60 (2003) 53-60
32. Nam S.Y., Kim K.R., Cha B.S., Song Y.D., Lim S.K., Lee H.C., and Huh K.B. Low-dose growth hormone treatment combined with diet restriction decreases insulin resistance by reducing visceral fat and increasing muscle mass in obese type 2 diabetic patients. Int. J. Obes. Relat. Metab. Disord. 25 (2001) 1101-1107
33. Johannsson G., Marin P., Lonn L., Ottosson M., Stenlof K., Bjorntorp P., Sjostrom L., and Bengtsson B.A. Growth hormone treatment of abdominally obese men reduces abdominal fat mass, improves glucose and lipoprotein metabolism, and reduces diastolic blood pressure. J. Clin. Endocrinol. Metab. 82 (1997) 727-734
34. Van Harmelen V., Reynisdottir S., Eriksson P., Thorne A., Hoffstedt J., Lonnqvist F., and Arner P. Leptin secretion from subcutaneous and visceral adipose tissue in women. Diabetes 47 (1998) 913-917
35. Svensson J., Herlitz H., Lundberg P.A., and Johannsson G. Adiponectin, leptin, and erythrocyte sodium/lithium countertransport activity, but not resistin, are related to glucose metabolism in growth hormone-deficient adults. J. Clin. Endocrinol. Metab. 90 (2005) 2290-2296